Published in Clin Exp Immunol on January 01, 1972
The biological activities of soluble lymphocyte products. Clin Exp Immunol (1972) 2.58
Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin Exp Immunol (1972) 1.94
Delayed hypersensitivity and acquired cellular resistance in guinea pigs infected with Listeria monocytogenes. Infect Immun (1975) 1.33
Contact sensitivity in the pig. Immunology (1973) 1.30
Cell-mediated immunity after bacterial infection of the lower respiratory tract. J Clin Invest (1974) 1.20
Products of activated lymphocytes. I. The use of radiolabeling techniques in the characterization and partial purification of the migration inhibition factor of the guinea pig. J Exp Med (1973) 1.16
A sensitive technique for measuring specific macrophage aggregation: a comparison with macrophage migration inhibition, for the detection of lymphokine activity. Immunology (1979) 1.12
In vitro correlates of delayed hypersensitivity in man: ambiguity of polymorphonuclear neutrophils as indicator cells in leukocyte migration test. Infect Immun (1973) 1.04
Studies on the production and action of polymorph migration stimulator. Clin Exp Immunol (1976) 0.89
Studies on the mechanism of macrophage aggregation induced by lymphokines. Immunology (1979) 0.88
Isolation of substances responsible for lymphokine activity from sensitized mouse spleen cells. Infect Immun (1974) 0.79
Studies on guinea-pig macrophage migration inhibitory factor (MIF). II. Purification of MIF after treatment with reducing and denaturing agents. Clin Exp Immunol (1979) 0.77
Presence and production of migration inhibitory activity in the peritoneal cavity. Immunology (1977) 0.75
The biochemistry of lymphocyte-derived mediators of immunological inflammation. Agents Actions (1978) 0.75
[A micro-method of immuno-electrophoresis]. Int Arch Allergy Appl Immunol (1955) 52.23
Efficient trace-labelling of proteins with iodine. Nature (1958) 23.16
Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (1966) 13.12
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A (1966) 12.29
"Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature (1969) 6.42
Reactions in vivo and in vitro produced by a soluble substance associated with delayed-type hypersensitivity. Proc Natl Acad Sci U S A (1968) 4.57
Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis. Cell Immunol (1970) 2.86
The clinical significance of mediators of cellular immunity. Clin Allergy (1971) 2.03
Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin Exp Immunol (1972) 1.94
Effect of antigenic competition on antigen-sensitive cells and on adoptively transferred immunocompetent cells. Cell Immunol (1970) 1.71
In vitro studies of cell-mediated immunity. I. Induction of lymphocyte transformation by a soluble "mitogenic" factor derived from interaction of sensitized guinea-pig lymphoid cells with specific antigen. Immunology (1970) 1.60
The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics. J Antimicrob Chemother (1976) 18.58
Plasmid-mediated beta-lactamases of Gram-negative bacteria: properties and distribution. J Antimicrob Chemother (1979) 7.39
"Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature (1969) 6.42
Analytical isoelectric focusing of R factor-determined beta-lactamases: correlation with plasmid compatibility. J Bacteriol (1976) 5.07
Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol (1970) 4.50
Types of beta-lactamase determined by plasmids in gram-negative bacteria. J Bacteriol (1979) 4.01
Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. J Gen Microbiol (1976) 3.54
A micro-method for peripheral leucocyte migration in tuberculin sensitivity. J Clin Pathol (1971) 3.45
Delayed hypersensitivity in the guinea-pig to a protein-hapten conjugate and its relationship to in vitro transformation of lymph node, spleen, thymus and peripheral blood lymphocytes. Immunology (1967) 3.33
Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol (1972) 3.08
R-factor mediated beta-lactamase production by Haemophilus influenzae. J Med Microbiol (1975) 2.75
Acquisition by Escherichia coli of plasmid-borne beta-lactamases normally confined to Pseudomonas spp. Plasmid (1979) 2.32
Properties of the beta-lactamase specified by the Pseudomonas plasmid RPL11. J Bacteriol (1977) 2.29
Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin Exp Immunol (1976) 2.20
Interleukin 1 in Crohn's disease. Clin Exp Immunol (1987) 2.18
Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig. Clin Exp Immunol (1972) 2.15
Tissue-specific antigens. Adv Immunol (1966) 2.15
'Lymphokines': molecular mediators of cellular immune responses in animals and man. Proc R Soc Med (1970) 2.13
The role of the macrophage in delayed hypersensitivity. Br Med Bull (1967) 2.07
The clinical significance of mediators of cellular immunity. Clin Allergy (1971) 2.03
Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin Exp Immunol (1972) 1.94
Plasmid-determined beta-lactamase indistinguishable from the chromosomal beta-lactamase of Escherichia coli. J Bacteriol (1976) 1.69
Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet (1982) 1.68
In vitro studies of cell-mediated immunity. I. Induction of lymphocyte transformation by a soluble "mitogenic" factor derived from interaction of sensitized guinea-pig lymphoid cells with specific antigen. Immunology (1970) 1.60
Acyclovir kinetics after intravenous infusion. Clin Pharmacol Ther (1979) 1.52
Lymphocyte mitogenic factor in man. Nature (1969) 1.51
A controlled evaluation of dermabrasion versus CO2 laser resurfacing for the treatment of perioral wrinkles. Plast Reconstr Surg (2000) 1.51
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
The distribution of beta-lactamase genes on plasmids found in Pseudomonas. Plasmid (1979) 1.43
Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.43
Standardization of the leucocyte migration test. Int Arch Allergy Appl Immunol (1973) 1.39
Change designation of clotting factors to Arabic numerals. J Thromb Haemost (2009) 1.39
The disposition of acyclovir in different species. J Pharmacol Exp Ther (1981) 1.38
Cytokines in proliferative vitreoretinopathy. Eye (Lond) (1991) 1.26
Immunity to malaria. 3. Possible occurrence of a cell-mediated immunity to Plasmodium knowlesi in chronically infected and Freund's complete adjuvant-sensitized monkeys. Exp Parasitol (1970) 1.24
Experimental cutaneous leishmaniasis: VI: anergy and allergy in the cellular immune response during non-healing infection in different strains of mice. J Clin Lab Immunol (1978) 1.20
Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii. Clin Exp Immunol (1974) 1.17
Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology (1988) 1.15
Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles). Clin Exp Immunol (1973) 1.14
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol (1989) 1.12
Immunoflorescence studies of Leishmania enriettii infection in the guinea pig. Trans R Soc Trop Med Hyg (1974) 1.11
IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin Exp Immunol (1996) 1.11
Peripheral leucocyte migration. Inhibited by diphtheroid organisms isolated from patients with rheumatoid arthritis. Ann Rheum Dis (1970) 1.10
Delayed hypersensitivity and desensitization to chemical haptens: antigenic specificity of delayed hypersensitivity. Br Med Bull (1967) 1.09
The production of lymphocyte mitogenic factor and migration-inhibition factor by antigen-stimulated lymphocytes of subjects with grass pollen allergy. Clin Exp Immunol (1971) 1.09
Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans. Antimicrob Agents Chemother (1982) 1.07
Cell-mediated immunity in anorexia nervosa. Clin Exp Immunol (1986) 1.07
Lymphocyte transformation. Absence of increased responses in alleged halothane jaundice. JAMA (1973) 1.07
Anaesthesia for renal transplantation in sickle cell disease. Can J Anaesth (1990) 1.06
Reduced sensory gating of the P1 potential in rape victims and combat veterans with posttraumatic stress disorder. Depress Anxiety (1999) 1.06
Cardiovascular effects of thyroxine. Cardiovasc Res (1969) 1.06
Simultaneous measurements of the accumulation of isotope-labelled protein and erythrocytes in skin reactions of allergic inflammation in the guinea-pig. Immunology (1972) 1.05
Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res (1994) 1.05
Germinal centre proliferation in response to mitogenic lymphokines. Clin Exp Immunol (1974) 1.05
Histological features of skin reactions to human lymphoid cell line lymphokine in patients with advanced cancer. J Pathol (1982) 1.03
An improved method for the purification of retinal S-antigen using selective hydrophobic adsorption chromatography. J Immunol Methods (1987) 1.02
Heat shock protein peptides reactive in patients with Behçet's disease are uveitogenic in Lewis rats. Clin Exp Immunol (1994) 1.00
A longitudinal study of clinical and immunological findings in 52 patients with relapsing retinal vasculitis. Br J Ophthalmol (1988) 1.00
Endothelial cell presentation of antigen to human T cells. Hum Immunol (1981) 0.99
Autoimmune mechanisms in inflammatory eye disease. Trans Ophthalmol Soc U K (1985) 0.99
Thymus and bursa dependence of lymphocyte mitogenic factor in the chicken. Nat New Biol (1972) 0.98
Correlation of serological and biochemical groupings of Yersinia enterocolitica with the beta-lactamases of the strains. J Gen Microbiol (1977) 0.98
Statewide diffusion of 100% tobacco-free college and university policies. Tob Control (2010) 0.97
Experimental posterior uveitis. I: A clinical, angiographic, and pathological study. Br J Ophthalmol (1987) 0.96
Numerical immunotaxonomy of Leishmania. I. Differentiation of four strains of Leishmania by serological tests. Immunology (1976) 0.94
Species differences in the disposition of acyclovir. Am J Med (1982) 0.94
Selective up-regulation of human granulocyte integrins and complement receptor 1 by cytokines. Immunology (1991) 0.94
Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2. Immunology (1989) 0.94
Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol (1994) 0.93
Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol (1998) 0.93
Proliferative vitreoretinopathy: an examination of the involvement of lymphocytes, adhesion molecules and HLA-DR antigens. Graefes Arch Clin Exp Ophthalmol (1993) 0.92
Rapid cytokine up-regulation of integrins, complement receptor 1 and HLA-DR on monocytes but not on lymphocytes. Immunology (1992) 0.91
Rheumatoid blood decreases the adherence of polymorphonuclear cells (PMNs) to cultured endothelium. Ann Rheum Dis (1987) 0.91
Rheumatoid and normal synovial tissue in longterm culture. Evidence of cell heterogeneity and an approach to quantitation of of populations and the effect of passage. J Rheumatol (1978) 0.90
Morphometric analysis of T lymphocyte compartmentation in experimental autoimmune uveoretinitis. Clin Exp Immunol (1989) 0.90
Blood mononuclear cells from patients with psoriasis exhibit an enhanced adherence to cultured vascular endothelium. J Invest Dermatol (1991) 0.88
Passive administration of antibody against retinal S-antigen induces electroretinographic supernormality. Invest Ophthalmol Vis Sci (1992) 0.88
The culture of vascular endothelial cells to confluence on microporous membranes. Thromb Res (1982) 0.88
Immunogenicity of a ribosomal antigen of Leishmania enriettii. Trans R Soc Trop Med Hyg (1971) 0.88
The effects of antibodies on cells. 3. Studies on the interaction of rat liver mitochondria and lysosomes with antibody and complement. Immunology (1965) 0.88
The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production. Clin Exp Immunol (2000) 0.88
Leucocyte chemotactic activity in the parallel bioassay of guinea--pig lymphokines. Immunology (1977) 0.87
Accelerated cytodifferentiation of antibody-secreting cells in guinea-pig lymph nodes stimulated by sheep erythrocytes and lymphokines. Clin Exp Immunol (1975) 0.87
Reduction of the surface charge of blood polymorphonuclear cells by rheumatoid sera and heat induced aggregated human IgG (HAGG). Ann Rheum Dis (1988) 0.86
Concanavalin A as an inducer of human lymphocyte mitogenic factor. Nat New Biol (1972) 0.86